tm logo

Monitor this mark

View On USPTO

BAQSIMI
Live/Registered
REGISTERED

on 07 May 2019

Last Applicant/ Owned by

AMPHASTAR PHARMACEUTICALS, INC.

11570 6TH STREET

RANCHO CUCAMONGA

CA

91730

Serial Number

86648904 filed on 02th Jun 2015

Registration Number

5745744 registered on 07th May 2019

in the Principal Register

Correspondent Address

Alyssa M. Worsham

Alyssa M. Worsham Wilson Sonsini Goodrich & Rosati

Palo Alto, CA 94304-1050

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

BAQSIMI

Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction

First Use Date in General

20th Mar 2019

First Use Date in Commerce

20th Mar 2019

Mark Details

Serial Number

No 86648904

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 47670-TM100

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
07th May 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
26th Sep 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
26th Sep 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26th Sep 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26th Sep 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26th Sep 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
23rd Aug 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07th May 2019REGISTERED-PRINCIPAL REGISTER
03rd Apr 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Apr 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED